tiprankstipranks
Recce Pharmaceuticals Ltd. (AU:RCE)
ASX:RCE
Australian Market

Recce Pharmaceuticals Ltd. (RCE) Financial Statements

Compare
8 Followers

Recce Pharmaceuticals Ltd. Financial Overview

Recce Pharmaceuticals Ltd.'s market cap is currently AU$100.86M. The company's EPS TTM is AU$-0.091; its P/E ratio is ―; Recce Pharmaceuticals Ltd. is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total RevenueAU$ 0.00AU$ 4.37MAU$ 3.08MAU$ 1.64MAU$ 1.12M
Gross ProfitAU$ -366.77KAU$ 4.15MAU$ 2.90MAU$ 1.34MAU$ 920.91K
Operating IncomeAU$ -22.05MAU$ -17.33MAU$ -14.15MAU$ -15.36MAU$ -5.41M
EBITDAAU$ -21.35MAU$ -16.99MAU$ -10.80MAU$ -14.77MAU$ -5.13M
Net IncomeAU$ -17.66MAU$ -13.08MAU$ -10.99MAU$ -13.51MAU$ -4.32M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 4.42MAU$ 1.56MAU$ 11.58MAU$ 20.87MAU$ 2.68M
Total AssetsAU$ 6.37MAU$ 2.56MAU$ 12.62MAU$ 21.68MAU$ 3.24M
Total DebtAU$ 811.19KAU$ 250.57KAU$ 74.76KAU$ 126.95KAU$ 83.23K
Net DebtAU$ -3.60MAU$ -1.31MAU$ -11.51MAU$ -20.75MAU$ -2.60M
Total LiabilitiesAU$ 15.89MAU$ 5.14MAU$ 2.56MAU$ 1.18MAU$ 931.53K
Stockholders' EquityAU$ -9.52MAU$ -2.59MAU$ 10.06MAU$ 20.50MAU$ 2.31M
Cash Flow
Free Cash FlowAU$ -13.15MAU$ -12.73MAU$ -9.05MAU$ -7.93MAU$ -3.81M
Operating Cash FlowAU$ -13.01MAU$ -12.69MAU$ -9.01MAU$ -7.86MAU$ -3.81M
Investing Cash FlowAU$ -141.90KAU$ -38.63KAU$ -40.34KAU$ -76.01KAU$ -5.94K
Financing Cash FlowAU$ 16.00MAU$ 2.71MAU$ -240.50KAU$ 26.12MAU$ 6.09M
Currency in AUD

Recce Pharmaceuticals Ltd. Earnings and Revenue History

Recce Pharmaceuticals Ltd. Debt to Assets

Recce Pharmaceuticals Ltd. Cash Flow

Recce Pharmaceuticals Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis